Join the club for FREE to access the whole archive and other member benefits.

Corina Amor Vegas

Assistant Professor at Cold Spring Harbor Laboratory

Corina joined Cold Spring Harbor Laboratory as an Independent Fellow in January 2022. The CSHL Fellows program offers promising young investigators the opportunity to establish their own research group shortly after completing graduate work. Corina received an M.D. from Universidad Complutense de Madrid in Spain in 2017 and then enrolled in the Gerstner Sloan Kettering Graduate School at Memorial Sloan Kettering Cancer Center in NY where she earned a Ph.D conducting her doctoral research in the laboratory of Scott W Lowe. Her thesis work focused on developing immune-based strategies to target senescent cells. This included studies to identify surface markers of senescent cells, pioneering the use of CAR T cells as senolytics and the development of flexible somatic cancer mouse models. Her work on senolytic CAR T cells was widely highlighted in leading journals in the field and earned her the Chairman’s Prize Award from Memorial Sloan Kettering. In 2022 Corina established her own research group whose goal is to study cellular senescence in cancer and aging with a focus on senescence immune surveillance and the development of cell-based senolytics.

Visit website: https://www.amorlab.org/people/

 corina-amor-md-phd-a9759887

 corina_amor_MD

See also: Institute Cold Spring Harbor Laboratory (CSH) - Biomedical research and education lab with programs in cancer, neuroscience, plant biology and quantitative biology

Details last updated 18-Jun-2020

Corina Amor Vegas News

T cells engineered to target and remove damaged cells in mice

T cells engineered to target and remove damaged cells in mice

Medical News Today - 31-Jan-2024

The treated mice showed better health, including improved metabolism and activity

New immune cells can recognise and eliminate a specific protein on ageing cells

New immune cells can recognise and eliminate a specific protein on ageing cells

Live Forever Club - 25-Jan-2024

In mice, this therapy was shown to reduce the number of senescent cells

Genetically engineered T cells can be used to target and kill senescent cells

Genetically engineered T cells can be used to target and kill senescent cells

Medical Xpress - 17-Jun-2020

Tested successfully in mice with liver fibrosis and lung cancer